Genenta Science SpA

Research Genenta Science SpA (GNTA) on Bullrun: market cap USD 27.13M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerGNTA
ExchangeNASDAQ
CountryItaly
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
Market capUSD 27.13M
Financial periodQ4 2025

Valuation Snapshot

latest market cap is USD 27.13M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 27.13M	n/a	n/a	n/a
2025	2025-12-31	USD 34.91M	n/a	n/a	n/a
2024	2024-12-31	USD 79.56M	n/a	n/a	n/a
2023	2023-12-29	USD 90.17M	n/a	n/a	n/a
2022	2022-12-30	USD 100.19M	n/a	n/a	n/a
2021	2021-12-31	USD 199.66M	n/a	n/a	n/a

About Genenta Science SpA

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications.

Related stock research

Italy stocks Italy Healthcare stocks A-Z stock index

Other Healthcare stocks

ARTERRA BIOSCIENCE (ARBS.MI) HELYX INDUSTRIES (HLX.MI) NEWRON PHARMACEUT. EO-20 (NP5) PHARMANUTRA S.P.A. (761) Amplifon S.p.A (AXNA) FARMACOSMO (COSMO.MI) EL.EN. S.P.A. (EE5) EUKEDOS (EUK.MI) GAROF HEALTH CARE (GHC.MI) GIUNTI (GPSY.MI) Media Lab SpA (MLLAB) OTOFARMA (OTO.MI)

Frequently asked questions

What is Genenta Science SpA's market cap?

Genenta Science SpA's market capitalization is USD 27.13M.